Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma
NCT03568461
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
98
Enrollment
INDUSTRY
Sponsor class
Conditions
Follicular Lymphoma
Interventions
BIOLOGICAL:
tisagenlecleucel
Sponsor
Novartis Pharmaceuticals